FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2683261339> ?p ?o ?g. }

• W2683261339 abstract "ABSTRACT Despite years of research and clinical advances, chronic pulmonary infections with mucoid Pseudomonas aeruginosa remain the primary concern for cystic fibrosis patients. Much of the research on these strains has focused on the contributions of the polysaccharide alginate; however, it is becoming evident that the neutral polysaccharide Psl also contributes to biofilm formation and the maintenance of chronic infections. Here, we demonstrate that Psl produced by mucoid strains has significant roles in biofilm structure and evasion of immune effectors. Though mucoid strains produce less Psl than nonmucoid strains, the Psl that is produced is functional, since it mediates adhesion to human airway cells and epithelial cell death. Additionally, Psl protects mucoid bacteria from opsonization and killing by complement components in human serum. Psl production by mucoid strains stimulates a proinflammatory response in the murine lung, leading to reduced colonization. To determine the relevance of these data to clinical infections, we tested Psl production and biofilm formation of a panel of mucoid clinical isolates. We demonstrated three classes of mucoid isolates, those that produce Psl and form robust biofilms, those that did not produce Psl and have a poor biofilm phenotype, and exopolysaccharide (EPS) redundant strains. Collectively, these experimental results demonstrate that Psl contributes to the biofilm formation and immune evasion of many mucoid strains. This is a novel role for Psl in the establishment and maintenance of chronic pulmonary infections by mucoid strains. IMPORTANCE Cystic fibrosis patients are engaged in an ongoing battle against chronic lung infections by the bacterium Pseudomonas aeruginosa . One key factor contributing to the maintenance of chronic infections is the conversion to a mucoid phenotype, where the bacteria produce copious amounts of the polysaccharide alginate. Once the bacteria become mucoid, existing treatments are poorly effective. We proposed that mucoid bacteria produce an additional polysaccharide, Psl, which is important for their establishment and maintenance of chronic infections. This work demonstrates that Psl enhances attachment of mucoid bacteria to lung surfaces and leads to inflammation and damage in the lung. Additionally, we find that 50% of mucoid bacteria isolated from patients with chronic infections rely on Psl for the structure of their biofilm communities, suggesting that treatments against Psl should be investigated to enhance the success of current therapies." @default.
• W2683261339 created "2017-06-30" @default.
• W2683261339 creator A5040336000 @default.
• W2683261339 creator A5056310890 @default.
• W2683261339 date "2017-07-05" @default.
• W2683261339 modified "2023-10-14" @default.
• W2683261339 title "Psl Produced by Mucoid <i>Pseudomonas aeruginosa</i> Contributes to the Establishment of Biofilms and Immune Evasion" @default.
• W2683261339 cites W1497725591 @default.
• W2683261339 cites W1674478883 @default.
• W2683261339 cites W1757304708 @default.
• W2683261339 cites W1763235239 @default.
• W2683261339 cites W1837361346 @default.
• W2683261339 cites W1923596380 @default.
• W2683261339 cites W1936661643 @default.
• W2683261339 cites W1947636021 @default.
• W2683261339 cites W1955670445 @default.
• W2683261339 cites W1963949581 @default.
• W2683261339 cites W1969537603 @default.
• W2683261339 cites W1970800237 @default.
• W2683261339 cites W1983414539 @default.
• W2683261339 cites W2032074166 @default.
• W2683261339 cites W2034852346 @default.
• W2683261339 cites W2042569858 @default.
• W2683261339 cites W2043346930 @default.
• W2683261339 cites W2050588950 @default.
• W2683261339 cites W2052675415 @default.
• W2683261339 cites W2055767311 @default.
• W2683261339 cites W2062846053 @default.
• W2683261339 cites W2095324134 @default.
• W2683261339 cites W2095415260 @default.
• W2683261339 cites W2096797367 @default.
• W2683261339 cites W2098375088 @default.
• W2683261339 cites W2102237761 @default.
• W2683261339 cites W2106351298 @default.
• W2683261339 cites W2111809348 @default.
• W2683261339 cites W2122116421 @default.
• W2683261339 cites W2124439712 @default.
• W2683261339 cites W2126879410 @default.
• W2683261339 cites W2134256289 @default.
• W2683261339 cites W2138134673 @default.
• W2683261339 cites W2144283370 @default.
• W2683261339 cites W2155894000 @default.
• W2683261339 cites W2157495301 @default.
• W2683261339 cites W2162335168 @default.
• W2683261339 cites W2165752657 @default.
• W2683261339 cites W2165797239 @default.
• W2683261339 cites W2166832761 @default.
• W2683261339 cites W2167279371 @default.
• W2683261339 cites W2168241903 @default.
• W2683261339 cites W2169545551 @default.
• W2683261339 cites W2169931992 @default.
• W2683261339 cites W2171155970 @default.
• W2683261339 cites W2179075918 @default.
• W2683261339 cites W2219714852 @default.
• W2683261339 cites W2326585024 @default.
• W2683261339 cites W2401334874 @default.
• W2683261339 cites W4253969210 @default.
• W2683261339 doi "https://doi.org/10.1128/mbio.00864-17" @default.
• W2683261339 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5478896" @default.
• W2683261339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28634241" @default.
• W2683261339 hasPublicationYear "2017" @default.
• W2683261339 type Work @default.
• W2683261339 sameAs 2683261339 @default.
• W2683261339 citedByCount "78" @default.
• W2683261339 countsByYear W26832613392017 @default.
• W2683261339 countsByYear W26832613392018 @default.
• W2683261339 countsByYear W26832613392019 @default.
• W2683261339 countsByYear W26832613392020 @default.
• W2683261339 countsByYear W26832613392021 @default.
• W2683261339 countsByYear W26832613392022 @default.
• W2683261339 countsByYear W26832613392023 @default.
• W2683261339 crossrefType "journal-article" @default.
• W2683261339 hasAuthorship W2683261339A5040336000 @default.
• W2683261339 hasAuthorship W2683261339A5056310890 @default.
• W2683261339 hasBestOaLocation W26832613391 @default.
• W2683261339 hasConcept C10464949 @default.
• W2683261339 hasConcept C203014093 @default.
• W2683261339 hasConcept C2524010 @default.
• W2683261339 hasConcept C2776938444 @default.
• W2683261339 hasConcept C2777637488 @default.
• W2683261339 hasConcept C33923547 @default.
• W2683261339 hasConcept C523546767 @default.
• W2683261339 hasConcept C54355233 @default.
• W2683261339 hasConcept C58123911 @default.
• W2683261339 hasConcept C86803240 @default.
• W2683261339 hasConcept C8891405 @default.
• W2683261339 hasConcept C89423630 @default.
• W2683261339 hasConceptScore W2683261339C10464949 @default.
• W2683261339 hasConceptScore W2683261339C203014093 @default.
• W2683261339 hasConceptScore W2683261339C2524010 @default.
• W2683261339 hasConceptScore W2683261339C2776938444 @default.
• W2683261339 hasConceptScore W2683261339C2777637488 @default.
• W2683261339 hasConceptScore W2683261339C33923547 @default.
• W2683261339 hasConceptScore W2683261339C523546767 @default.
• W2683261339 hasConceptScore W2683261339C54355233 @default.
• W2683261339 hasConceptScore W2683261339C58123911 @default.
• W2683261339 hasConceptScore W2683261339C86803240 @default.
• W2683261339 hasConceptScore W2683261339C8891405 @default.
• W2683261339 hasConceptScore W2683261339C89423630 @default.
• W2683261339 hasFunder F4320332161 @default.

• next